Concepedia

Publication | Open Access

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

DOIFull Paper Access

249

Citations

21

References

2019

Year

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, Albert Oriol, David Simpson, Anupkumar George, Hartmut Goldschmidt, Alessandra Larocca, Asher Chanan‐Khan, Daniel W. Sherbenou,
The Lancet Haematology

References

YearCitations

Page 1